Boston's resTORbio Sets Terms for $85M IPO Post author:Sam Post published:January 16, 2018 Post category:BioPharma resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace You Might Also Like Media Mogul Dumps $125 Million Theranos Stake for $1 March 26, 2017 Can This Region Become the Country???s Next Big Biotech Hub for Jobs? July 19, 2017 Providence Medical Technology Snags New FDA Clearances for Standalone Use of CAVUX Cervical Cage-L System and ALLY Facet Screws March 28, 2017
Providence Medical Technology Snags New FDA Clearances for Standalone Use of CAVUX Cervical Cage-L System and ALLY Facet Screws March 28, 2017
